经皮冠状动脉介入治疗后标准剂量与高剂量氯吡格雷的比较 - Suppr | 超能文献

Standard- vs high-dose clopidogrel after percutaneous coronary intervention.

作者信息

Jeong Young-Hoon, Park Yongwhi, Kim In-Suk

出版信息

JAMA. 2011 Jun 22;305(24):2520; author reply 2521-2. doi: 10.1001/jama.2011.842.

DOI:10.1001/jama.2011.842

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Standard- vs high-dose clopidogrel after percutaneous coronary intervention.

JAMA. 2011 Jun 22;305(24):2520; author reply 2521-2. doi: 10.1001/jama.2011.842.

2

Standard- vs high-dose clopidogrel after percutaneous coronary intervention.

JAMA. 2011 Jun 22;305(24):2520-1; author reply 2521-2. doi: 10.1001/jama.2011.843.

3

Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.

JACC Cardiovasc Interv. 2010 Jul;3(7):731-41. doi: 10.1016/j.jcin.2010.05.007.

4

The worry about clopidogrel "nonresponsiveness": identification and treatment in the post-percutaneous coronary intervention patient.

JACC Cardiovasc Interv. 2009 Nov;2(11):1102-4. doi: 10.1016/j.jcin.2009.09.005.

5

Carriage of reduced-function CYP2C19 allele among patients treated with clopidogrel.

JAMA. 2011 Feb 2;305(5):467-8; author reply 468. doi: 10.1001/jama.2011.77.

6

Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.

JACC Cardiovasc Interv. 2011 Apr;4(4):381-91. doi: 10.1016/j.jcin.2010.12.010.

7

Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping.

JACC Cardiovasc Interv. 2011 Apr;4(4):403-10. doi: 10.1016/j.jcin.2010.12.011.

8

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.

Clin Pharmacol Ther. 2011 Aug;90(2):328-32. doi: 10.1038/clpt.2011.132. Epub 2011 Jun 29.

9

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

JAMA. 2011 Mar 16;305(11):1097-105. doi: 10.1001/jama.2011.290.

10

Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study.

JACC Cardiovasc Interv. 2009 Nov;2(11):1095-101. doi: 10.1016/j.jcin.2009.08.018.

引用本文的文献

1

"East asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome.

Curr Cardiol Rep. 2014 May;16(5):485. doi: 10.1007/s11886-014-0485-4.